Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov
Sections
Personal tools
Log in
 
You are here: Home › Publications › A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus.

A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus.

Meltzer SJ. A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus.. Cancer Res .

Announcement